MedPath

INEZOLID (PNU 100766) IN THE TREATMENT OF PNEUMONIA BY ESTREPTOCOCO PNEUMONIAE. A DOUBLE BLIND ASSESSMENT STUDYING THE INTRAVENOUS ADMINISTRATION OF LINEZOLID WITH ORAL CONTINUATION COMPARED TO THE INTRAVENOUS ADMINISTRATION OF SODIUM CEFTRIAXONE FOLLOWED BY THE ORAL ADMINISTRATION OF PROXETIL CEFPODOXYM.

Not Applicable
Conditions
-J18
J18
Registration Number
PER-016-98
Lead Sponsor
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

NA

Exclusion Criteria

NA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath